Vinblastine Sulfate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 10 mg/10 mL (1 mg/mL), 10 mg/1 mL
Reference Brands: Velban® (EU & US)
Category: Oncology Cancer Care
Vinblastine Sulfate (brand Velban®) is a chemotherapy drug used to treat lymphomas, testicular cancer, and Kaposi's sarcoma. Supplied as a 10 mg/10 mL IV injection, it stops cancer cell division by blocking microtubule formation. Available through GMP-compliant B2B suppliers in the US and EU. Vinblastine sulfate is available in Injection and strengths such as 10 mg/10 mL (1 mg/mL), 10 mg/1 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Vinblastine sulfate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Vinblastine sulfate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Vinblastine Sulfate, marketed under the brand name Velban®, is a potent chemotherapy agent used in the treatment of Hodgkin and non-Hodgkin lymphoma, testicular cancer, Kaposi's sarcoma, and more. Available as an intravenous injection in strengths like 10 mg/10 mL, Vinblastine works by disrupting microtubule formation to inhibit cancer cell division. It is widely sourced by B2B pharmaceutical buyers across the US and EU, offering GMP-certified quality and consistent availability. Trusted in oncology protocols, Vinblastine is essential for hospitals and distributors seeking reliable cancer therapies through global supply chains.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Motixafortide Acetate
Strength:
1 mg/mL
Form: Injection
Reference Brands: Aphexda (USA)
View DetailsMomelotinib
Strength:
100 mg, 150 mg, 200 mg
Form: Tablets
Reference Brands: Ojjaara (USA)
View DetailsNirogacestat
Strength:
50 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers